Xiaohui Luo

Xiaohui Luo

Auto-generated profile, based on publicly available information

Xiaohui Luo

College of Food and Health, Zhejiang Agriculture and Forestry University, Hangzhou 311300, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Food Bioscience
Verified
Journal Article
Closed access
XLXiaohui Luo
Xiaohui Luo
Shaozhen WuShaozhen Wu
Shaozhen Wu
JXJiawen Xue
Jiawen Xue
HHHao Hu
Hao Hu
ZHZhiping He
Zhiping He
FWFenghua Wu
Fenghua Wu

18 May 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
FWFenghua Wu
Fenghua Wu
XLXiaohui Luo
Xiaohui Luo
YZYongzhu Zhang
Yongzhu Zhang
PWPeng Wang
Peng Wang
YCYinzi Chang
Yinzi Chang
XLXingquan Liu
Xingquan Liu
Torreya grandis meal has a high protein content and an appropriate amino acid ratio, making it an excellent protein source for producing ACE inhibitory peptides. To promote its application in food, medicine, and other fields, an alkaline protease hydrolysate of Torreya grandis was used in this study to isolate and identify a novel angiotensin-converting enzyme inhibitory peptide, VNDYLNW (VW-7), using ultrafiltration, gel chromatography purification, LC-MS/MS, and in silico prediction. The results show that the IC50 value of VW-7 was 205.98 µM. The Lineweaver–Burk plot showed that VW-7 had a mixed-type inhibitory effect on ACE. Meanwhile, according to the results of molecular docking, VW-7 demonstrated a strong affinity for ACE (binding energy −10 kcal/mol). VW-7 was bound to ACE through multiple binding sites. In addition, VW-7 could remain active during gastrointestinal digestion in vitro. Nitric oxide (NO) generation in human endothelial cells could rise after receiving a pretreatment with VW-7. These results indicated that Torreya grandis meal protein can be developed into products with antihypertensive function, and VW-7 has broad application prospects in the field of antihypertensive.